Covid19

Novel COVID-19 Antiviral Ensitrelvir Provides Earlier Symptom Relief in Phase 3 Trial

Owing to the need for COVID-19 treatments for patients without risk factors for severe disease, researchers investigated the efficacy and safety of …

Read more at www.infectiousdiseaseadvisor.com

Show More

Related Articles

Back to top button